Bleeding News and Research

RSS

Aspirin might well be considered the top utility player in the medicine cabinet

This cheap over-the-counter drug can be used not only for fever, pain and arthritis, but to prevent heart attack, stroke or angina. It also may reduce the risk of colorectal cancer. Yet aspirin also has side effects worth considering, and its very accessibility may hamper its use.

8 Oct 2004

Canadian Rheumatology Association issues statement on Vioxx alternatives

The Canadian Rheumatology Association (CRA) has issued a statement to its 350 members and other interested parties, recommending alternative treatment considerations in the wake of the worldwide recall of Merck's rofecoxib, (Vioxx(R)) last week.

7 Oct 2004

Ultrasound offers new diagnosis for whiplash injury

Lengthy waits for personal injury compensation after car crashes could be a thing of the past, thanks to research being carried out at The University of Nottingham.

6 Oct 2004

Receiving a blood transfusion is associated with a greater risk of death for patients with acute coronary syndromes

The use of invasive procedures for treatment of ischemic heart disease has more than tripled in the past 2 decades and is likely to increase in high-risk patients, according to background information in the article.

5 Oct 2004

Researchers discover new mechanism responsible for blood vessel tumors that cause facial deformities

Researchers have discovered a new mechanism responsible for the growth of blood vessel tumors that can cause facial deformities in infants and young children, paving the way for an antibody-based treatment to remove cells that fuel the tumors’ growth.

5 Oct 2004

Episiotomy does not reduce the risk of injury to infants during a complicated birth

A new study from Johns Hopkins suggests that routine widening of the vagina, a procedure known as an episiotomy, does not reduce the risk of injury to infants during a complicated birth, such as when a baby's shoulders are stuck in the birth canal after the head is already out.

4 Oct 2004

Data demonstrate that Celebrex does not increase the risk of heart attack or stroke in patients with arthritis and pain

Pfizer has said that three large long-term Celebrex (celecoxib capsules) studies involving more than 6,000 patients have not shown any significant safety issues and are expected to continue to completion.

4 Oct 2004

Women aged 16 to 19 are 43% more likely to test positive for Chlamydia than women in their early twenties

Women aged 16 to 19 are 43% more likely to test positive for Chlamydia than women in their early twenties, show data from the first year of the Chlamydia screening programme in England, reported in Sexually Transmitted Infections.

29 Sep 2004

Arsenic trioxide - invented as a treatment for a rare type of leukaemia

Arsenic trioxide – a highly poisonous substance best known as an effective weed killer or pesticide and notorious for being a favourite ‘weapon’ of choice in murder mystery novels, is being re-invented as a treatment for a rare type of leukaemia.

28 Sep 2004

Steps to minimise the risk of onward transmission of vCJD

Selected groups of patients are this week being notified about the results of a risk assessment exercise for blood plasma products.

22 Sep 2004

Microdebrider better than CO2 laser for removal of most pediatric airway lesions

Citing improved safety and effectiveness at lower cost, a major medical center has adopted the microdebrider to replace the CO2 laser for removal of most pediatric airway lesions, including stenoses, granulation tissue, and cysts.

18 Sep 2004

Coronary angioplasty within 24 hours of medical therapy could improve the outcome for heart-attack patients

Results of a randomised trial in this week’s issue of THE LANCET suggest that a more aggressive approach involving coronary angioplasty soon after anticlotting medical therapy is safe and could offer a better prognosis than more conservative treatment for patients who have had heart attack.

17 Sep 2004

Paintball injuries are sending more and more patients to the emergency room every year

The incidence of paintball eye injuries treated in emergency rooms has risen from an estimated 545 in 1998 to approximately 1,200 in 2000, according to a recent report in the journal Pediatrics.

16 Sep 2004

Wyeth gets approval for needle-less syringe for the treatment of hemophilia

Wyeth Pharmaceuticals has announced that it has received approval from the U.S. Food and Drug Administration (FDA) for the ReFacto Antihemophilic Factor (Recombinant) R2 Kit, the first needle-less reconstitution device with a prefilled diluent syringe for hemophilia.

14 Sep 2004

Herbals, surgery and anesthesia don't always mix

The woman who swears by gingko biloba wonders why her mouth won't stop bleeding after wisdom tooth surgery. What she doesn't know is that the herbal remedy she takes religiously to enhance mental alertness also acts as a powerful blood thinner that inhibits clotting.

10 Sep 2004

John Reid has announced further developments concerning variant Creutzfeldt-Jakob disease

He told MPs in a written ministerial statement that an exercise has begun to notify some recipients of blood products about the results of a risk assessment exercise carried out by the Health Protection Agency.

10 Sep 2004

Genetically modified fish may help treat hemophiliacs

A human blood-clotting factor used to treat some people with haemophilia and accident victims suffering serious bleeding has been produced using genetically modified fish.

9 Sep 2004

Pig tissue may help reduce the damage and disability of stroke

A tiny capsule containing tissue that secretes a cocktail of brain-nourishing neurotrophic factors may one day help reduce the damage and disability of stroke, according to research published in the September issue of Stroke.

7 Sep 2004

Bone marrow produces cells that permanently heal wounds

Bone marrow produces cells that not only help fight infection but also permanently heal wounds, according to research at the University of Washington. Previously, researchers had not known that bone marrow contributed to the development of new skin in wounds.

5 Sep 2004

Benefit of using clot-busting drug tissue plasminogen activator (tPA) for ischemic stroke

An independent review of data from a landmark clinical trial has validated the benefit of using the clot-busting drug tissue plasminogen activator (tPA) for ischemic stroke, when given within three hours of symptom onset under a strict treatment protocol.

2 Sep 2004